BBCR Voice
From the Perspective of Researchers, Clinicians, and Regulatory Experts
The most efficient path in the clinical research process is a moving target. Technology innovation and regulatory requirements require constant updates. Through BBCR Voice, we aim to share not only our knowledge and expertise but also solutions to current challenges. BBCR embraces the challenges of developers and investors seeking a more straightforward path to market.
Recent Posts
What is Strategic Clinical Innovation Organization
The Strategic Clinical Innovation Organization (SCIO) concept provides biotech, pharmaceutical and device manufacturing companies with a cost-effective, customized approach to clinical development planning. This approach, pioneered by BBCR, aims to reduce the risks...
Getting More Drugs Approved for Rare Diseases
There’s encouraging news for rare diseases experts and patients. Today, pharmaceutical companies are devoting more resources to developing treatments for less-common disorders and diseases that affect mostly minority populations. The trend, which is slowly...
The cost of Trial Failure- ImmusanT Celiac Drug Trial Failure ‘Devastating’
Dec 23, 2014- Cambridge-based ImmusanT Inc. has raised $12 million in financing for its celiac-fighting immunotherapy Nexvax2 and its two celiac diagnostic tools, funding that will progress the clinical trials and development of both...
Understanding Personalized Medicine
Personalized medicine or precision medicine is a medical model emphasizing the customization of healthcare, with all decisions and practices being tailored to individual patients in whatever ways possible. Precision medicine seeks to provide an objective basis for...
Innovation in Rare Diseases
In the last three decades, biopharmaceutical companies have made great progress in the fight against rare, or “orphan,” diseases (each of which affect fewer than 200,000 people in the United States) and scientists are working each day to make the coming...
BBCR is Hiring! Boston Biotech Clinical Research is looking for a Full Time Associate Clinical Scientist to join our team!
CAREERS Job Opening: Full Time Associate Clinical Scientist About Boston Biotech Clinical Research, LLC BBCR is a global clinical-regulatory consulting, rare disease expert, offering strategic, innovative and cost-effective solutions to small and medium drug...
Is There Room in the Pharma Industry for Small Niche Providers?
As many Pharma companies scramble to partner with large CRO’s, is there still room in the industry for the small niche provider? Over 70 comments from Pharma professionals with both client and vendor experience contributed. While many Pharma groups are seduced by the...
Overcoming Barriers to Patient Recruitment in Clinical Trials
Clinical research organizations face a multitude of challenges in recruiting and enrolling patients for clinical trials. Studies show that general barriers to a patient’s enrollment include a fear of being a “guinea pig,” concerns about the complexity of research...
Patient-Centricity: Empower and inform patients making them partners in the research process
In recent years, the American healthcare system as a whole has attracted a great deal of scrutiny, which has heralded a continuous series of efforts aimed at improving and optimizing the system. In the midst of such developments, a question has emerged for those with...
Patient-Centricity: Tailoring Treatments to Individual Patients
The concept of patient-centricity is inherently multifaceted; it encompasses both the recognition of participants as central to clinical trials and the possibility of tailoring clinical interventions to individuals. Recently, the latter notion has been the subject of...
BBCR Consulting announces the first edition of comprehensive insights into biomarker discovery and development.
BBCR Consulting announces the first edition of comprehensive insights into biomarker discovery and development Handbook of Biomarkers and Precision Medicine Edited by Claudio Carini, Mark Fidock, Alain van Gool "The field of Biomarkers and Precision Medicine in...
Innovative Strategies Address Risks Related to Multiple Sclerosis Treatments
Progressive multifocal leukoencephalopathy (PML) is a rare but devastating neurological disease that affects the immunosuppressed population. The etiologic agent is a polyomavirus, JC virus – a double stranded DNA virus with a high prevalence of infection...
Drug development success hinges on simplifying Clinical Research
SCIO Strategic Consulting Sponsor companies are using a variety of outsourcing relationship models. The Tufts CSDD completed a review and analysis of the different outsourcing relationships. Three functional areas were identified as clinical study requirements: 1....
Strategies that De-Risk Clinical Trials
Why clinical strategy is important for clinical trial success. Since the 1990s, the pharma industry has experienced increasing R&D expenditure and number of candidates entering development. The average number of news drugs approved by FDA per year, however, has...
Strategic Consulting: The convergence revolution to innovate clinical trial process
SCIO Strategic Consulting Convergence is the results of sharing methods and ideas across multidisciplinary fields of science and industries. The Convergence revolution, despite is challenged by industry, educational and government constrains, offers a real solution to...
Strategic Consulting – SCIO Process -A New Way for Drug Development
SCIO Strategic Consulting SCIO is critical to accelerate approval and significantly reduce costs. Declining pharmaceutical industry productivity is well recognized by drug developers, regulatory authorities and patient groups. Despite the fast growth of the sector,...
Strategic consulting reduces cost and risk of clinical trials
SCIO Strategic Consulting The Strategic Clinical Innovation Organization (SCIO) concept provides biotech, pharmaceutical and device companies with a cost-effective, customized approach to clinical development. This approach, pioneered by BBCR, reduces the risks...
SCIO Helps Early Stage Biotech Company Evaluation
SCIO Strategic Consulting The creation of the concept for a Strategic Clinical Innovation Organization (SCIO) has been evolving over the past 10 years as the market has become aware of the risk from the lack of “upfront” clinical strategy and development...
A success story by BBCR Consulting: Candida Fratazzi MD was CMO at Ichorion Therapeutics in 2018
Thanks to strategic and expert work focused on product positioning and development with risk reduction, in only 8 months, Ichorion Therapeutics was acquired by Cerecor. Transaction worth approximately $26.6 Million in Stock Plus Potential Milestones Accelerates...
Welcome to BBCR’s New Website!
We are pleased to share with you our new website. Over the past several months, our team has carefully reviewed our processes, capabilities, and offerings in order to provide you with the clearest overview of how we help our clients. The SCIO approach we take in...